Since its 2017 approval as a diabetes treatment, semaglutide (the generic name for Ozempic and its offshoots, Rybelsus and Wegovy) has become one of the most popular prescription drugs in the U.S
From patients losing over 100 pounds to clinical trials showing double-digit body fat reduction, semaglutide consistently delivers results that diets alone cant match
The protocol of this study was approved by the Ethical Committee of Peking University Third Hospital
Nutrition counseling may be insufficient for individuals who face significant barriers to healthy eating, such as food insecurity, nutrition insecurity, or insufficient time or income
It is unclear how these findings relate to changes in glycemic control in patients with type 2 diabetes
Statements made are not intended to diagnose, treat, cure, or prevent any disease